Skip to content
10-K

Annual Report

Orthofix Medical Inc. OFIX

0000950170-25-026066

← back to feed
Filed
Feb 25, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2024 · Feb 21, 2025 39.02M sh
Long Term Debt FY 2024 · Dec 31, 2023 $93.11M
Short Term Debt FY 2024 · Dec 31, 2023 $1.25M
Current Liabilities FY 2024 · Dec 31, 2023 $165.22M
Total Liabilities FY 2024 · Dec 31, 2023 $326.59M
Current Assets FY 2024 · Dec 31, 2023 $420.44M
Total Assets FY 2024 · Dec 31, 2023 $925.32M
Shares Diluted FY 2024 · Dec 31, 2022 20.05M sh
Operating Cash Flow FY 2024 · Dec 31, 2022 −$11.54M
Cash And Equivalents FY 2024 · Dec 31, 2022 $50.7M
Eps Diluted FY 2024 · Dec 31, 2022 −$0.98
Eps Basic FY 2024 · Dec 31, 2022 −$0.98
Sga Expense FY 2024 · Dec 31, 2022 $308.78M
Rd Expense FY 2024 · Dec 31, 2022 $49.07M
Net Income FY 2024 · Dec 31, 2022 −$19.75M
Operating Income FY 2024 · Dec 31, 2022 −$13.27M
Gross Profit FY 2024 · Dec 31, 2022 $337.17M
Cost Of Revenue FY 2024 · Dec 31, 2022 $123.54M
Revenue FY 2024 · Dec 31, 2022 $460.71M
Stockholders Equity FY 2024 · Dec 31, 2021 $336.93M